CBG stands for cannabigerol, which is a cannabinoid found in the cannabis plant. It is considered a minor cannabinoid as it is usually found in lower concentrations than other cannabinoids such as THC and CBD.
Like other cannabinoids, CBG interacts with the endocannabinoid system (ECS) in the human body. CBG is thought to work by binding to the CB1 and CB2 receptors in the ECS, which are responsible for regulating many bodily functions such as mood, appetite, sleep, and pain sensation.
CBG is believed to have a range of potential therapeutic benefits, including anti-inflammatory and pain-relieving properties. Some studies have also suggested that CBG may have antibacterial properties and could be effective in treating conditions such as glaucoma, Huntington's disease, and inflammatory bowel disease (IBD).
However, much more research is still needed to fully understand the effects of CBG on the human body and its potential therapeutic benefits.